Related references
Note: Only part of the references are listed.Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
Luis Villar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The protein DIIIC-2, aggregated with a specific oligodeoxynucleotide and adjuvanted in alum, protects mice and monkeys against DENV-2
Lazaro Gil et al.
IMMUNOLOGY AND CELL BIOLOGY (2015)
Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
Maria Rosario Capeding et al.
LANCET (2014)
Viral kinetics of primary dengue virus infection in non-human primates: A systematic review and individual pooled analysis
Benjamin M. Althouse et al.
VIROLOGY (2014)
Olive baboons: a non-human primate model for testing dengue virus type 2 replication
Iris Valdes et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2013)
An Alphavirus Vector-Based Tetravalent Dengue Vaccine Induces a Rapid and Protective Immune Response in Macaques That Differs Qualitatively from Immunity Induced by Live Virus Infection
Laura J. White et al.
JOURNAL OF VIROLOGY (2013)
The global distribution and burden of dengue
Samir Bhatt et al.
NATURE (2013)
Safety and Immunogenicity of a Recombinant Tetravalent Dengue Vaccine in 9-16 Year Olds A Randomized, Controlled, Phase II Trial in Latin America
Luis A. Villar et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2013)
Identifying protective dengue vaccines: Guide to mastering an empirical process
Scott B. Halstead
VACCINE (2013)
Rational Design of a Live Attenuated Dengue Vaccine: 2 '-O-Methyltransferase Mutants Are Highly Attenuated and Immunogenic in Mice and Macaques
Roland Zuest et al.
PLOS PATHOGENS (2013)
Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
Arunee Sabchareon et al.
LANCET (2012)
Efficacy of a Tetravalent Chimeric Dengue Vaccine (DENVax) in Cynomolgus Macaques
Jorge E. Osorio et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2011)
Common marmoset (Callithrix jacchus) as a primate model of dengue virus infection: development of high levels of viraemia and demonstration of protective immunity
Tsutomu Omatsu et al.
JOURNAL OF GENERAL VIROLOGY (2011)
A Single Dose of the DENV-1 Candidate Vaccine rDEN1Δ30 Is Strongly Immunogenic and Induces Resistance to a Second Dose in a Randomized Trial
Anna P. Durbin et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Discrepancy in Dengue Virus Neutralizing Antibody Titers between Plaque Reduction Neutralizing Tests with Fcγ Receptor (FcγR)-Negative and FcγR-Expressing BHK-21 Cells
Meng Ling Moi et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Protection against dengue virus by non-replicating and live attenuated vaccines used together in a prime boost vaccination strategy
Monika Simmons et al.
VIROLOGY (2010)
Dengue Plaque Reduction Neutralization Test (PRNT) in Primary and Secondary Dengue Virus Infections: How Alterations in Assay Conditions Impact Performance
Stephen J. Thomas et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2009)
Viremia and the Magnitude of the Immune Response upon Infection of Green Monkeys with Dengue Virus Type 2 Are Strain-Dependent
Jorge Martin et al.
CURRENT MICROBIOLOGY (2009)
Viremia and antibody response in green monkeys (Chlorocebus aethiops sabaeus) infected with dengue virus type 2: A potential model for vaccine testing
Jorge Martin et al.
MICROBIOLOGY AND IMMUNOLOGY (2009)
Immunological evaluation in nonhuman primates of formulations based on the chimeric protein P64k-domain III of dengue 2 and two components of Neisseria meningitidis
Iris Valdes et al.
VACCINE (2009)
Guidelines for plaque-reduction neutralization testing of human antibodies to dengue viruses
John T. Roehrig et al.
VIRAL IMMUNOLOGY (2008)
Primary and secondary infections of Macaca fascicularis monkeys with Asian and American genotypes of dengue virus 2
Lidice Bernardo et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Efficacy of a live attenuated tetravalent candidate dengue vaccine in naive and previously infected cynomolgus macaques
Penelopie Koraka et al.
VACCINE (2007)
A chimeric tetravalent dengue DNA vaccine elicits neutralizing antibody to all four virus serotypeg in rhesus macaques
Kanakatte Raviprakash et al.
VIROLOGY (2006)
An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model
JR Putnak et al.
VACCINE (2005)
Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys
JE Blaney et al.
JOURNAL OF VIROLOGY (2005)
Safety and efficacy of chimeric yellow fever-dengue virus tetravalent vaccine formulations in nonhuman primates
F Guirakhoo et al.
JOURNAL OF VIROLOGY (2004)
Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections
DH Libraty et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Share Paper
